ExpressCells

📍 Philadelphia, United States🗓 Founded 2018👥 7 employees💰 Last funded Sep 2019
Biotechnology🌐 xpresscells.com
Website LinkedIn
Biological researchers need to identify how new drugs and biologics works within cells. To do so, they test these products in cell lines: human cells propagated in lab culture. These cell lines are often genetically altered in order to study a specific protein but current processes take 4-6 months, the modifications are limited, and altered cells are often killed in order to study the protein of interest. ExpressCells has a superior technology that does not have these limitations. We use CRISPR plus our proprietary genetic vector system to create custom cells for research 4X faster. Our living cells can replicate diseases or have proteins glow in multiple colors. Learn more by following us on Twitter at https://twitter.com/expresscells
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2018
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in ExpressCells?
ExpressCells has 1 investors on record on gritt.io, including 1 early-stage backers.
When did ExpressCells last raise funding?
The most recent investment in ExpressCells recorded on gritt.io was in September 2019.
When was ExpressCells founded?
ExpressCells was founded in 2018.
What industry is ExpressCells in?
ExpressCells operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is ExpressCells based?
ExpressCells is headquartered in Philadelphia, United States.